INTRODUCTION
LaEnnec has been credited with the first description of anemia in association with lead poisoning (1) . Numerous attempts to define the responsible pathogenetic mechanisms have shown that no single factor is completely culpable, since the demonstrable deleterious effects of lead on erythrocytes in vitro and in vivo are multiple and varied (1, 2) . These include defects both in globin (3, 4) and in heme (3, 5, 6 ) synthesis with resultant retardation of erythrocyte maturation and di-A portion of this work has appeared in abstract form: 1974. J. Clin. Invest. 53: 58a.
Received for publication 19 May 1975. rect membrane effects with impaired cation pumping (7) (8) (9) (10) (11) , altered fragilities (12) , and consequent hemolysis.
The present studies evolved from recent recognition of an hereditary hemolytic syndrome in which erythrocytes were characterized in part by prominent basophilic stippling and a specific enzyme deficiency (13) . The defective enzyme was a pyrimidine 5'-nucleotidase (5'-ribonucleotide phosphohydrolase, EC 3.1.3.5) not known to exist in other tissues. In normal hemolysates, it hydrolytically dephosphorylates uridine and cytidine but it is ineffective with AMP, other purine ribonucleotides, or with substrates commonly used for assay of nonspecific acid or alkaline phosphatases. Enzymatic activity was found to be markedly sensitive to heavy metal inhibition (14) . The latter characteristic and the occurrence of prominent basophilic stippling in both the hereditary deficiency state and in severe plumbism prompted the present studies to investigate a possible causal relation between lead-induced anemia and this metal's specific effect on erythrocyte pyrimidine 5'-nucleotidase.
METHODS
Venous blood, anticoagulated with heparin, was obtained from normal healthy volunteers and, in a single-blind study, from subjects accidentally exposed to lead as a consequence of their occupations. Erythrocytes were separated from leukocytes and platelets by sedimentation in Plasmagel or by cotton filtration followed by multiple saline washes. Activities of enzymes of the Embden-Meyerhof pathway, the pentosephosphate pathway, and glutathione and nucleotide metabolism and of certain nonglycolytic enzymes were measured by methods noted in earlier reports (13, (15) (16) (17) (18) (19) (20) . Erythrocyte glutathione concentration was determined by the method of Beutler et al. (21) .
Hemolysates prepared by alternate freezing and thawing were dialyzed free of endogenous phosphates before assaying 5'-nucleotidase activity as detailed previously (13, 14) . The assay system employed aliquots of dialyzed hemolysate incubated at 370C with 2.3 mM UMP or CMP as substrate in 25 mM Tris buffer with 10 mM MgCl2 at a final pH of 7.8. Inorganic phosphate (P.) liberated by nucleotidase activity was determined by the Fiske and SubbaRow technique (22) after terminating the reaction by deproteinization with trichloroacetic acid. Activities were expressed as micromoles of Pi evolved per hour per gram of hemoglobin. Duplicate determinations with each substrate were performed, providing a minimum of four nucleotidase assays on each subj ect. Nucleotide ultraviolet absorption spectra were determined on acid extracts of washed erythrocytes as described previously (13) .
Appropriate specimens from individuals subjected to lead overburden were also sent to a commercial laboratory for routine hematologic measurements and for assays of blood and urinary lead concentrations and urinary 5-aminolevulinic acid excretion. These findings were not reviewed until completion of erythrocyte enzyme studies.
RESULTS
Effect of lead on pyrimidine-5'-nucleotidase activities in normal hemolysates. In vitro effects of lead on erythrocyte nucleotidase were assessed by addition of the divalent acetate salt directly to buffered hemolysate during the 1-2-h incubation phase of the assay. Results in Fig. 1 were incubated at 370C for 20 min with varying concentrations of lead acetate, then dialyzed at 40C against two 1,500-vol changes of the same dialysis medium for 31 and 171 h before assaying nucleotidase activities.
Inhibitory effects were similar in magnitude to those observed with lead present directly in the assay medium (solid curve in Fig. 1 (14) . Studies on subjects with lead overburden. Most of the exposed individuals had subjective symptoms referable to lead toxicity, such as irritability, difficulty sleeping, gastrointestinal complaints including crampy abdominal pain, and other signs of peripheral or central nervous system effects. At the time of study, only one subject had anemia, and this was mild. Hemoglobin levels averaged 15.2 g/100 ml, and the lowest value was 12.7 g/100 ml with a reticulocyte count of 2.1%.
Basophilic stippling was not observed in peripheral erythrocytes from any subject. Results of routine hematologic studies and lead toxicity assays are presented in Table II. Erythrocyte pyrimidine-5'-nucleotidase activities were below normal control values in all 15 subjects with lead overburden, averaging 2.6 and 2.4 U, respectively, with UMP and CMP as substrates. Corresponding normal laboratory values are 6.6 U (SD, 2.0 U) and 5.5 U (SD, 1.4 U). Mean activities in these subjects were equivalent to 39% (with UMP) and 44% (with CMP) of normal controls and ranged from 11 to 70% (UMP) and from 12 to 82% (CMP) of normal means.
The lowest nucleotidase activity observed (< 0.7 U) occurred in the only subject with mild anemia (hemoglobin, 12.7 g/100 ml; reticulocytes, 2.1%). This was equivalent to 11-12% of normal mean values, but was effectively somewhat lower, since this nucleotidase is characteristically more active in younger erythrocytes and reticulocytes (14) . Blood lead concentration and urinary lead excretion in this patient were 80 lyg/100 ml and 218 isg/24 h, respectively, 4 days before performance of enzyme assays.
The subject with the greatest overburden on the basis of blood lead concentration (109 fug/100 ml, 18 days previously) had the second lowest nucleotidase activities recorded, 1.35 and 1.45 U with UMP and CMP, respectively.
Intervals between lead toxicity analyses recorded in Table II and assays of erythrocyte enzyme activities varied from 0 to 41 days, averaging 15 days, so direct temporal relations could not be established. Despite this, blood lead concentrations in these patients exhibited general correlations with pyrimidine-5'-nucleotidase activities in their erythrocytes (Fig. 2) . There was no apparent correlation between nucleotidase activities and either lead or 5-aminolevulinic acid excretion in the urine.
Specimens from 12 subjects were also assayed for activities of other erythrocyte enzymes. Results presented in the second part of Table I demonstrate the selective depression of pyrimidine-5'-nucleotidase activities in these patients. In some individuals, slightly lowered values were found for phosphoglycerate kinase, triosephosphate isomerase, phosphofructokinase, and (1, 2) . It seems clear that lead affects both erythroid precursor cells and mature circulating erythrocytes, resulting in impaired erythroid maturation, defective heme synthesis, sideroblastosis in some instances, and distinct hemolytic tendencies. The latter may be due in part to slight but specific effects on membrane components, including ATPase (9, 10, 23), which cause affected cells to be selected for early removal by a discriminating reticuloendothelial system or which induce premature osmotic lysis.
As noted previously, defective hemoglobinization is probably the consequence of impaired globin formation Effects of Lead on Human Erythrocyte Enzymes combined with specific enzymatic defects in protoporphyrin and heme synthetic pathways. The latter include variable inhibitions of heme synthetase (24) and of 8-aminolevulinic acid synthetase (24) (25) (26) and dehydratase (25) (26) (27) (28) , accounting for the elevated blood and urine concentrations of those intermediates of porphyrin and heme metabolism that are characteristic of lead toxicity.
These inhibitory effects on multiple enzyme systems (and/or structural proteins) are presumably due to effects on critical protein sulfhydryl groups. Sulfhydrylrich enzymes, such as those of heme biosynthesis, are thus expecially susceptible (1, 6) . Waldron suggested that anemia might be due not only to effects on heme synthesis but also on enzymes concerned with glycolysis (1). Glycolytic impairment, however, does not appear to be a significant factor under conditions of this investigation. Our observations support those of Rogers et al. (27) , who did not measure activities of individual glycolytic enzymes but found lactate and C02 production from glucose to be normal in erythrocytes from rabbits with experimentally induced lead poisoning (blood lead levels, 117-+14 ig/100 ml). Our observations regarding malic dehydrogenase, acetylcholinesterase (measured on only three subjects), acid phosphatase, and glucose-6-phosphate dehydrogenase are also in accord with theirs, although their report cites conflicting data on the latter (27) . Glutathione content, usually thought to be decreased in lead toxicity (2), was not significantly altered, a finding supported by that of Angle and McIntire (23) .
The present studies demonstrate a manifestation of lead toxicity that may relate to the occurrence of basophilic stippling and premature hemolysis in some cases of plumbism. Mature erythrocytes exposed to low concentrations of lead, either in vivo or in vitro, exhibited substantial, sometimes marked, decreases in activity of pyrimidine 5'-nucleotidase. This enzyme was inhibited at lead concentrations that exerted minimal effects on a wide variety of other erythrocyte enzymes assayed simultaneously. Such lead-induced impairment of pyrimidine-5'-nucleotidase activity prompts comparison with the genetically induced, severe deficiency state involving this same enzyme (13, 29, 30) . The latter is characterized clinically by severe chronic hemolytic anemia with pronounced basophilic stippling of the erythrocytes that uniquely contain large amounts of uridine and cytidine nucleotides. The presence of high concentrations of pyrimidine nucleotides may secondarily affect the activities of critical glycolytic enzymes, such as the kinases, by competition with the preferred and far more efficient adenine nucleotide cofactors (13) and possibly by other mechanisms such as feedback inhibition. It should be emphasized that these manifestations were not observed in individuals heterozygous for the deficiency, who had approximately half-normal nucleotidase activities, but only in homozygotes with residual nucleotidase activities that were 10% of normal or less, even in the presence of marked reticulocytosis. Normal reticulocytes and young erythrocytes exhibit nucleotidase activities considerably increased above those in more mature cell populations (13, 14) .
Both the basophilic reticulum of normal reticulocytes and the basophilic granules of stippled erythrocytes are composed of RNA (31, 32) which may be in the form of aggregated ribosomes in lead poisoning (33) . In patients with severe hereditary nucleotidase deficiency, the granules presumably result from retarded RNA degradation secondary to inability to dephosphorylate and render diffusible the pyrimidine degradation products of RNA (13) . In the present study, despite clear evidence of lead overburden, neither increased intracellular pyrimidine nucleotides nor basophilic stippling were evident, and anemia was absent in virtually all subjects. Absence of frank basophilic stippling and anemia in many adults with chronic lead intoxication has been documented in other studies (1, 2) . Blood lead levels must exceed about 110 lg/100 ml before clinically evident depression of hemoglobin concentration generally occurs (34) .
The present studies suggest that with greater degrees of lead overburden, such as in cases of severe acute poisoning, erythrocyte nucleotidase activity might well be more deficient and uniformly distributed and thereby more closely resemble the genetically determined, homozygous deficiency state. If such were the case, anemia, demonstrable hemolysis, increased basophilic stippling, and elevated intracellular concentrations of uridine and cytidine nucleotides would be expected. Lack of appropriate clinical material has thus far precluded adequate assessment of this possibility.
